What does CUSIP 88322Q908 represent in this 13F holders report?

CUSIP 88322Q908 is the security identifier for 88322Q908 - TG THERAPEUTICS INC - COM - Call used to aggregate holder disclosures.

How many institutions held 88322Q908 - TG THERAPEUTICS INC - COM - Call in Q2 2024?

No institutional holders were reported for 88322Q908 - TG THERAPEUTICS INC - COM - Call in Q2 2024; review adjacent reporting periods for trend context.

TG THERAPEUTICS INC - COM - Call

CUSIP: 88322Q908

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / COM
Price per share: $17.79
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 88322Q908?
CUSIP 88322Q908 identifies 88322Q908 - TG THERAPEUTICS INC - COM - Call in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2024
Previous quarter: Q1 2024

Recent filing periods for CUSIP 88322Q908:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

TG THERAPEUTICS INC - COM - Call

Q2 2024 13F Holders as of 30 Jun 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of TG THERAPEUTICS INC - COM - Call as of Q2 2024.